Recent Updates
Recently added Catalysts
HAE Positive Sentiment

Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond...

Key Takeaway: Haemonetics Corporation announced that its President and CEO, Chris Simon, will participate in a fireside chat at the Raymond James 45th Annual Institutional Investors Conference on March 5, 2024. The event will be accessible via a live webcast, with a replay available for 90 days afterward. This engagement highlights Haemonetics' commitment to investor relations.
Price reaction · baseline $71.43 (2024-02-20 close) · hit after-hours · clean, no other HAE news in the window
day 0 close · peak
+2.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Haemonetics is participating in a prominent investor conference.
  • The event provides an opportunity for direct communication with investors.
  • The webcast allows broader access to the company's insights.

Full Press Release Details

BOSTON , Feb. 21, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE ) announced that Chris Simon , President and CEO, will participate in a fireside chat with investors at the Raymond James 45th Annual Institutional Investors Conference on Tuesday, March 5, 2024 at 7:30 a.m. ET .
The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://wsw.com/webcast/rj129/hae/1445840 . A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.
About Haemonetics
Haemonetics (NYSE: HAE ) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com .
Investor Contacts:
Olga Guyette, Sr. Director-Investor Relations & Treasury
David Trenk, Manager-Investor Relations
(781) 356-9763
(203) 733-4987
[email protected]
[email protected]
Media Contact:
Josh Gitelson, Director-Global Communications
(781) 356-9776
[email protected]

Frequently Asked Questions

When will Haemonetics present at the conference?

Haemonetics will present on March 5, 2024, at 7:30 a.m. ET.

How can I access the Haemonetics presentation?

The presentation can be accessed via a live webcast on Haemonetics' Investor Relations website.

Will there be a replay of the presentation?

Yes, a replay will be available 12 hours after the event for 90 days.

Who is representing Haemonetics at the conference?

Chris Simon, the President and CEO of Haemonetics, will represent the company.

Last updated: Feb 21, 2024